Jiuzhitang Co Ltd (SHE:000989) — Market Cap & Net Worth
Market Cap & Net Worth: Jiuzhitang Co Ltd (000989)
Jiuzhitang Co Ltd (SHE:000989) has a market capitalization of $984.47 Million (CN¥6.73 Billion) as of June 18, 2026. Listed on the SHE stock exchange, this China-based company holds position #9146 globally and #2331 in its home market, demonstrating a -0.51% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Jiuzhitang Co Ltd's stock price CN¥7.86 by its total outstanding shares 855942012 (855.94 Million). Review debt load of Jiuzhitang Co Ltd to assess the company's total debt and financial obligations.
Jiuzhitang Co Ltd Market Cap History: 2015 to 2026
Jiuzhitang Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $2.55 Billion to $984.47 Million (-6.92% CAGR).
Jiuzhitang Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Jiuzhitang Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.42x
Jiuzhitang Co Ltd's market cap is 0.42 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.61x
Jiuzhitang Co Ltd's market cap is 4.61 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $2.55 Billion | $871.51 Million | $471.03 Million | 2.93x | 5.41x |
| 2016 | $2.01 Billion | $2.67 Billion | $651.81 Million | 0.75x | 3.08x |
| 2017 | $1.76 Billion | $3.84 Billion | $721.42 Million | 0.46x | 2.44x |
| 2018 | $946.00 Million | $3.16 Billion | $336.48 Million | 0.30x | 2.81x |
| 2019 | $843.50 Million | $3.18 Billion | $192.15 Million | 0.26x | 4.39x |
| 2020 | $829.35 Million | $3.56 Billion | $272.31 Million | 0.23x | 3.05x |
| 2021 | $1.20 Billion | $3.78 Billion | $270.70 Million | 0.32x | 4.43x |
| 2022 | $1.02 Billion | $3.03 Billion | $357.99 Million | 0.34x | 2.84x |
| 2023 | $1.20 Billion | $2.96 Billion | $297.41 Million | 0.41x | 4.04x |
| 2024 | $997.00 Million | $2.37 Billion | $216.20 Million | 0.42x | 4.61x |
Competitor Companies of 000989 by Market Capitalization
Companies near Jiuzhitang Co Ltd in the global market cap rankings as of June 18, 2026.
Key companies related to Jiuzhitang Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #513 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #560 globally with a market cap of $48.78 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #631 globally with a market cap of $43.86 Billion USD ( CN¥299.75 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #634 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #513 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #560 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.27 |
| #631 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $43.86 Billion | CN¥46.99 |
| #634 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €13.30 |
Jiuzhitang Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Jiuzhitang Co Ltd's market cap moved from $2.55 Billion to $ 984.47 Million, with a yearly change of -6.92%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥984.47 Million | -9.97% |
| 2025 | CN¥1.09 Billion | +9.67% |
| 2024 | CN¥997.00 Million | -17.09% |
| 2023 | CN¥1.20 Billion | +18.19% |
| 2022 | CN¥1.02 Billion | -15.12% |
| 2021 | CN¥1.20 Billion | +44.52% |
| 2020 | CN¥829.35 Million | -1.68% |
| 2019 | CN¥843.50 Million | -10.83% |
| 2018 | CN¥946.00 Million | -46.16% |
| 2017 | CN¥1.76 Billion | -12.53% |
| 2016 | CN¥2.01 Billion | -21.21% |
| 2015 | CN¥2.55 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of Jiuzhitang Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $984.47 Million USD |
| MoneyControl | $984.47 Million USD |
| MarketWatch | $984.47 Million USD |
| marketcap.company | $984.47 Million USD |
| Reuters | $984.47 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Jiuzhitang Co Ltd
Jiuzhitang Co., Ltd. provides traditional Chinese, chemical, biological, and health medicine products in China. It offers Shuxuetong injections, Angong Niuhuang pills, Tianma Gouteng granules, Danxi granules, and Compound Lipid-Reducing tablets for cardiovascular and neurological treatment: Nude Flower Zizhu tablets, Xiaojin pills, Guizhi Fuling pills, Buxue Shengru granules, and Zhixue Zhentong … Read more